Frank Solis v. Millennium Pharmaceuticals, In, et al
| UNITED STATES OF AMERICA, ex rel. |
| MERCK & CO., INC., SCHERING-PLOUGH CORPORATION and MILLENNIUM PHARMACEUTICALS, INC. |
| FRANK SOLIS, United States of America ex rel. |
| 20-15682 |
| April 15, 2020 |
| U.S. Court of Appeals, Ninth Circuit |
| Other |
Opinions
We have the following opinions for this case:
| Description |
|---|
| FRANK SOLIS V. MILLENNIUM PHARM., INC. |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 8, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 Filed order MEDIATION (RSK): Appellants obligation to file mediation questionnaires in appeal nos. 20-15863 and 20-15864 are deemed satisfied. A dial-in telephone conference in appeal nos. 20-15863 and 20-15864 will be held in conjunction with appeal no. 20-15682 on May 26, 2020 at 10:00 a.m. Pacific Time. Each participant will receive an email modifying the dial-in information. [11685443] [20-15682, 20-15863, 20-15864] (AF) [Entered: 05/08/2020 03:07 PM] |
| Filing 9 DOCKETED CAUSE AND ENTERED APPEARANCES OF COUNSEL. SEND MQ: Yes. Setting cross-appeal briefing schedule as follows: Appellants Merck & Co., Inc. and Schering-Plough Corporation Mediation Questionnaire due on 05/13/2020. First cross appeal brief due 07/24/2020 for Frank Solis. Second brief on cross appeal due 08/24/2020 for Merck & Co., Inc., Millennium Pharmaceuticals, Inc. and Schering-Plough Corporation. Third brief on cross appeal due 09/23/2020 for Frank Solis. Optional cross appeal reply brief is due within 21 days of service of third brief on cross appeal. [11682046] [20-15864, 20-15682, 20-15863] (JBS) [Entered: 05/06/2020 09:44 AM] |
| Filing 8 DOCKETED CAUSE AND ENTERED APPEARANCES OF COUNSEL. SEND MQ: Yes. Setting cross-appeal briefing schedule as follows: Appellant Millennium Pharmaceuticals, Inc. Mediation Questionnaire due on 05/13/2020. First cross appeal brief due 07/24/2020 for Frank Solis. Second brief on cross appeal due 08/24/2020 for Merck & Co., Inc., Millennium Pharmaceuticals, Inc. and Schering-Plough Corporation. Third brief on cross appeal due 10/26/2020 for Frank Solis. Optional cross appeal reply brief is due within 21 days of service of third brief on cross appeal. [11682017] [20-15863, 20-15682] (JBS) [Entered: 05/06/2020 09:30 AM] |
| Filing 7 MEDIATION CONFERENCE SCHEDULED - DIAL-IN FurtherConference, 05/26/2020, 10:00 a.m., Pacific Time. See order for details. [11679287] (VS) [Entered: 05/04/2020 10:58 AM] |
| Filing 6 MEDIATION CONFERENCE SCHEDULED - DIAL-IN AssessmentConference, 05/04/2020, 10:00 a.m., PACIFIC Time. The briefing schedule previously set by the court remains in effect. See order for instructions and details. [11669473] (VS) [Entered: 04/23/2020 10:13 AM] |
| Filing 5 The Mediation Questionnaire for this case was filed on 04/21/2020. To submit pertinent confidential information directly to the Circuit Mediators, please use the following # link . Confidential submissions may include any information relevant to mediation of the case and settlement potential, including, but not limited to, settlement history, ongoing or potential settlement discussions, non-litigated party related issues, other pending actions, and timing considerations that may impact mediation efforts.[11667888]. [20-15682] (AD) [Entered: 04/21/2020 06:44 PM] |
| Filing 4 Terminated James M. Perez for Millennium Pharmaceuticals, Inc. in 20-15682 (due to incorrect ECF contact information) [11667831] (RY) [Entered: 04/21/2020 04:57 PM] |
| Filing 3 Deleted Incorrect Entry. Correct Entry: [4]. [11667817] (RY) [Entered: 04/21/2020 04:49 PM] |
| Filing 2 Filed (ECF) Appellant Frank Solis Mediation Questionnaire. Date of service: 04/21/2020. [11667289] [20-15682] (Parker, John) [Entered: 04/21/2020 12:59 PM] |
| Filing 1 DOCKETED CAUSE AND ENTERED APPEARANCES OF COUNSEL. SEND MQ: Yes. The schedule is set as follows: Appellant Frank Solis Mediation Questionnaire due on 04/22/2020. Transcript ordered by 05/15/2020. Transcript due 06/15/2020. Appellant Frank Solis opening brief due 07/24/2020. Appellees Merck & Co., Inc., Millennium Pharmaceuticals, Inc. and Schering-Plough Corporation answering brief due 08/24/2020. Appellant's optional reply brief is due 21 days after service of the answering brief. [11662290] (RT) [Entered: 04/15/2020 04:36 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
